Nephro Care India Management
Management criteria checks 0/4
Nephro Care India's CEO is Pratim Sengupta, appointed in Sep 2024, has a tenure of less than a year. directly owns 61.38% of the company’s shares, worth ₹2.24B. The average tenure of the management team and the board of directors is 0.7 years and 0.9 years respectively.
Key information
Pratim Sengupta
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | less than a year |
CEO ownership | 61.4% |
Management average tenure | less than a year |
Board average tenure | less than a year |
Recent management updates
Recent updates
CEO
Pratim Sengupta (48 yo)
less than a year
Tenure
Dr. Pratim Sengupta is Managing Director of Nephro Care India Limited (formerly known as Nephro Care India Private Limited) since March 04, 2024 and has been its Director since July 08, 2014 and also serve...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chief Financial Officer | 1.1yrs | ₹600.00k | 0.14% ₹ 5.0m | |
Company Secretary & Compliance Officer | less than a year | ₹74.00k | no data | |
MD, CEO & Chairman | less than a year | no data | 61.38% ₹ 2.2b |
0.7yrs
Average Tenure
48yo
Average Age
Experienced Management: NEPHROCARE's management team is not considered experienced ( 0.7 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
MD, CEO & Chairman | 10.3yrs | no data | 61.38% ₹ 2.2b | |
Independent Director | less than a year | no data | no data | |
Independent Director | less than a year | no data | no data | |
Independent Director | less than a year | no data | no data | |
Non-Executive Non-Independent Director | less than a year | no data | no data | |
Independent Director | less than a year | no data | no data | |
Independent Director | less than a year | no data | no data | |
Non Executive Non-Independent Director | 10.3yrs | no data | no data |
0.9yrs
Average Tenure
50yo
Average Age
Experienced Board: NEPHROCARE's board of directors are not considered experienced ( 0.9 years average tenure), which suggests a new board.